Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
Proteomic quantifications and experimental validation of plasma samples from three cohorts of COVID-19 patients with distinct symptoms at different time points identify differentially expressed host proteins that correlate with disease severity and prioritize biomarker combinations for accurately predicting COVID-19 clinical outcomes.